Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew Warner

Showing results (81-90 of 159) with videos related to

Pageof 16
Sort By:
International Journal of Radiation Oncology, Biology, Physics|December 10, 2023
Is Ultrahypofractionated Whole Pelvis Radiation Therapy (WPRT) as Well Tolerated as Conventionally Fractionated WPRT in Patients With Prostate Cancer? Early Results From the HOPE TrialLucas C Mendez, Juanita Crook, Kevin Martell, et al.
European Urology Oncology|January 4, 2026
Ultrahypofractionated Versus Conventionally Fractionated Whole-pelvis Radiotherapy in Prostate Cancer: A Randomized Clinical TrialLucas C Mendez, Juanita Crook, Kevin Martell, et al.
BMC Cancer|April 23, 2026
Re-evaluating previous dose and allowing increasing recovery (REPAIR): study protocol for a thoracic reirradiation phase I dose escalation trialDonna H Murrell, Nicolaus Andratschke, Alanah M Bergman, et al.
Radiation Oncology (London, England)|January 14, 2021
Predicting pathological complete response (pCR) after stereotactic ablative radiation therapy (SABR) of lung cancer using quantitative dynamic [<sup>18</sup>F]FDG PET and CT perfusion: a prospective exploratory clinical studyDae-Myoung Yang, David A Palma, Keith Kwan, et al.
JAMA Oncology|February 22, 2019
Measuring the Integration of Stereotactic Ablative Radiotherapy Plus Surgery for Early-Stage Non-Small Cell Lung Cancer: A Phase 2 Clinical TrialDavid A Palma, Timothy K Nguyen, Alexander V Louie, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|January 24, 2014
The prostate cancer risk stratification project: database construction and risk stratification outcome analysisGeorge Rodrigues, Himu Lukka, Padraig Warde, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 16, 2013
The prostate cancer risk stratification (ProCaRS) project: recursive partitioning risk stratification analysisGeorge Rodrigues, Himu Lukka, Padraig Warde, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|December 16, 2022
Prospective and Cross-sectional Associations of the Rectal Tissue Microbiome with Colorectal Adenoma RecurrenceDoratha A Byrd, Emily Vogtmann, Ana M Ortega-Villa, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|July 28, 2020
Is prostate brachytherapy a dying art? Trends and variation in the definitive management of prostate cancer in Ontario, CanadaMark T Corkum, Gerard Morton, Alexander V Louie, et al.
International Journal of Radiation Oncology, Biology, Physics|January 11, 2026
Practical Aspects of Delivering Radiation for Poly-metastatic DiseaseHatim Fakir, Gage Redler, Glenn S Bauman, et al.
Pageof 16

Showing results (81-90 of 159) with videos related to

Sort By:
Pageof 16
International Journal of Radiation Oncology, Biology, Physics|December 10, 2023
Is Ultrahypofractionated Whole Pelvis Radiation Therapy (WPRT) as Well Tolerated as Conventionally Fractionated WPRT in Patients With Prostate Cancer? Early Results From the HOPE TrialLucas C Mendez, Juanita Crook, Kevin Martell, et al.
European Urology Oncology|January 4, 2026
Ultrahypofractionated Versus Conventionally Fractionated Whole-pelvis Radiotherapy in Prostate Cancer: A Randomized Clinical TrialLucas C Mendez, Juanita Crook, Kevin Martell, et al.
BMC Cancer|April 23, 2026
Re-evaluating previous dose and allowing increasing recovery (REPAIR): study protocol for a thoracic reirradiation phase I dose escalation trialDonna H Murrell, Nicolaus Andratschke, Alanah M Bergman, et al.
Radiation Oncology (London, England)|January 14, 2021
Predicting pathological complete response (pCR) after stereotactic ablative radiation therapy (SABR) of lung cancer using quantitative dynamic [<sup>18</sup>F]FDG PET and CT perfusion: a prospective exploratory clinical studyDae-Myoung Yang, David A Palma, Keith Kwan, et al.
JAMA Oncology|February 22, 2019
Measuring the Integration of Stereotactic Ablative Radiotherapy Plus Surgery for Early-Stage Non-Small Cell Lung Cancer: A Phase 2 Clinical TrialDavid A Palma, Timothy K Nguyen, Alexander V Louie, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|January 24, 2014
The prostate cancer risk stratification project: database construction and risk stratification outcome analysisGeorge Rodrigues, Himu Lukka, Padraig Warde, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 16, 2013
The prostate cancer risk stratification (ProCaRS) project: recursive partitioning risk stratification analysisGeorge Rodrigues, Himu Lukka, Padraig Warde, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|December 16, 2022
Prospective and Cross-sectional Associations of the Rectal Tissue Microbiome with Colorectal Adenoma RecurrenceDoratha A Byrd, Emily Vogtmann, Ana M Ortega-Villa, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|July 28, 2020
Is prostate brachytherapy a dying art? Trends and variation in the definitive management of prostate cancer in Ontario, CanadaMark T Corkum, Gerard Morton, Alexander V Louie, et al.
International Journal of Radiation Oncology, Biology, Physics|January 11, 2026
Practical Aspects of Delivering Radiation for Poly-metastatic DiseaseHatim Fakir, Gage Redler, Glenn S Bauman, et al.
Pageof 16